The NSABP Foundation is a nonprofit organization with a history of conducting ground-breaking clinical trial research in breast and colorectal cancer.
Pittsburgh, PA
Joined January 2017
- Tweets3K
- Following208
- Followers853
- Likes3.3K
Since inception in 1957, the NSABP Foundation has designed and led numerous clinical trials pioneering new standards for treating breast and colorectal cancer. nsabp.org
28
🇺🇸 On #VeteransDay, we honor all who have served in our nation's Armed Forces. We are deeply grateful for the courage, dedication, and sacrifices of our veterans and their families. Thank you for your service and for all you have given to our country. ❤️🤍💙
#ThankYouVeterans
🇺🇸 On Veterans Day, we honor all who have served in our nation's Armed Forces. We are deeply grateful for the courage, dedication, and sacrifices of our veterans and their families. Thank you for your service & for all you have given to our country. ❤️🤍💙 #ThankYouVeterans
1
25
NSABP Foundation #research is driven by the goal to improve treatment options & advance the standard for care for #breastcancer & #colorectalcancer. Learn more: nsabp.org #clinicaltrialresearch
#Clinicaltrialresearch is vital. "Every new medicine and treatment started with volunteers participating in clinical trials." Learn more: nsabp.org #NSABPFoundation #CancerResearch
NSABP Foundation retweeted
Registration for the #NRG2027 Winter Meeting in Las Vegas is now open and we just posted the meeting agenda. Check it out and register soon! nrgoncology.org/meetings/202…
💗A little pink, a lot of team spirit! NSABP staff celebrated #BreastCancerAwarenessMonth with a fun office gathering in support of everyone impacted by breast cancer. Our commitment to advancing #breastcancer research & improving patient outcomes continues every day!💕
1
3
141
Full results from the NSABP B-59/GBG-96-GeparDouze substudy were recently published in JCO Precision Oncology, demonstrating the capability of the Oncodetect® MRD test to predict disease recurrence in triple-negative breast cancer (TNBC). Read more: ow.ly/E0HC50ZPe7j
1
107
Breast cancer research is more than studies and statistics. It is about people. The NSABP Foundation recognizes the patients & families who participate in research, the advocates who raise awareness & the researchers working to make better options possible.
#HappyHalloween
NSABP Foundation retweeted
Registration for the NRG2027 Winter Meeting is Now OPEN! Join us in exciting Las Vegas, NV - in-person Jan 28-30 and select virtual sessions being held Jan 21-26. Register soon to avoid the late registration fee ↪️ow.ly/EYzZ5102aIF
NSABP Foundation retweeted
NRG Oncology Patient Advocate Committee - Call for Membership. Read more & how to apply: conta.cc/4ifgrXO
NSABP Foundation retweeted
ICYMI – the October issue of the NRG Oncology newsletter is available. This issue highlights plenty of content for #BreastCancerAwarenessMonth. Check it out here: ow.ly/Cvce50ZXl9o
Early detection is the best defense against #breastcancer! Don't forget to schedule an appointment for a yearly mammogram! #BreastCancerAwarenessMonth
1
49
October is #BreastCancerAwarenessMonth. Participation in clinical trials is important to advancing breast cancer care. Learn more about NSABP Foundation studies that are currently open to enrollment on our website: nsabp.org
October is #BreastCancerAwarenessMonth. Early detection of #breastcancer can make a significant difference to the outcome of treating it. Please remember to schedule your yearly mammogram! Learn more about our breast cancer #ClinicalTrials: nsabp.org #bcsm
NSABP Foundation retweeted
Dr. Priya Rastogi recently shared insights with OncLive on the evolving role of ctDNA and MRD testing in breast cancer. ow.ly/Q3Xm50ZXkw8
Today is #NationalMammographyDay, observed annually on the 3rd Friday in October. Be sure to schedule your annual screening because early detection can help save lives! #BreastCancerAwarenessMonth
NSABP Foundation retweeted
NRG HCA Fellowship Call for Applications Reminder (due Oct 23). ow.ly/g57x50ZXktX
NSABP Foundation retweeted
OlympiA trial update – results demonstrate sustained benefit of adjuvant olaparib in germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer. Read more: nrgoncology.org/?post_type=n…
NSABP Foundation retweeted
Our October newsletter is out today! In this issue, #BreastCancerAwareness, NRG-BR009 OFSET Study update, PSC news, TrialMatch, FORTE, monthly Advocate Angle article & more! Check it out here: conta.cc/4rXp10B
